Premium
[O2–09–05]: SAFETY, TOLERABILITY, AND PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS OF PF‐06751979, A POTENT AND SELECTIVE ORAL BACE1 INHIBITOR: RESULTS FROM PHASE1 SINGLE AND MULTIPLE ASCENDING DOSE STUDIES IN HEALTHY YOUNG AND OLDER VOLUNTEERS
Author(s) -
Qiu Ruolun,
Liu Richann,
He Ping,
Wills AnneMarie,
Tankisheva Ekaterina,
Alvey Christine,
Buckeridge Clare,
Bednar Martin,
Alexander Robert C.,
Chen Danny
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.07.196
Subject(s) - tolerability , placebo , medicine , pharmacokinetics , pharmacodynamics , crossover study , adverse effect , pharmacology , gastroenterology , anesthesia , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom